Endovascular aortic repair with sac embolization for the prevention of type II endoleaks (the EVAR-SE study): study protocol for a randomized controlled multicentre study in Germany.

"Declarations Ethics approval and consent to participate {24}The study was approved by the Ethics Committees of the Medical Faculty, Technical University of Munich (Reference Number 2022-533-S-NP), the University of Augsburg (Reference Number 2022-533-S-NP), the Technical University of Dresden (Reference Number BO-EK-108032023), and the Hessian Medical Association (Reference Number 2023-3324-zvBO). Written, informed consent to participate will be obtained from all participants. Consent for publication {32}This publication does not contain any data allowing conclusions on individual patients. A model consent form as used in the EVAR-SE study will be provided on request. Competing interests {28}The authors declare that they have no competing interests. Competing interests {28} The authors declare that they have no competing interests."

"Funding {4} Open Access funding enabled and organized by Projekt DEAL. EVAR-SE is funded by the “Bundesministerium für Bildung und Forschung” (BMBF), project number (Förderkennzeichen): 01KG2128. Funding Open Access funding enabled and organized by Projekt DEAL."

"Trial registration ClinicalTrials.gov NCT05665101. Registered on 23 December 2022."